Lemaitre Vascular Stock Analysis
LMAT Stock | USD 98.65 1.66 1.71% |
LeMaitre Vascular is fairly valued with Real Value of 98.86 and Target Price of 98.78. The main objective of LeMaitre Vascular stock analysis is to determine its intrinsic value, which is an estimate of what LeMaitre Vascular is worth, separate from its market price. There are two main types of LeMaitre Vascular's stock analysis: fundamental analysis and technical analysis.
The LeMaitre Vascular stock is traded in the USA on NASDAQ Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA. LeMaitre Vascular is usually not traded on Labour Day, Thanksgiving Day, Christmas Day, New Year 's Day, National Mourning Day, Dr . Martin Luther King Jr 's Birthday, Washington 's Birthday, Good Friday, Memorial Day, Juneteenth Holiday, Independence Day. LeMaitre Stock trading window is adjusted to America/New York timezone.
LeMaitre |
LeMaitre Stock Analysis Notes
About 96.0% of the company shares are owned by institutional investors. The company has Price/Earnings To Growth (PEG) ratio of 2.16. LeMaitre Vascular last dividend was issued on the 21st of November 2024. LeMaitre Vascular, Inc. designs, markets, sells, services, and supports medical devices and implants for the treatment of peripheral vascular disease worldwide. LeMaitre Vascular, Inc. was incorporated in 1983 and is headquartered in Burlington, Massachusetts. Lemaitre Vascular operates under Medical Instruments Supplies classification in the United States and is traded on NASDAQ Exchange. It employs 450 people. To find out more about LeMaitre Vascular contact George LeMaitre at 781 221 2266 or learn more at https://www.lemaitre.com.LeMaitre Vascular Quarterly Total Revenue |
|
LeMaitre Vascular Investment Alerts
LeMaitre Vascular generated a negative expected return over the last 90 days | |
Over 96.0% of the company shares are owned by institutional investors | |
Latest headline from news.google.com: LeMaitre Vascular Now Covered by Wells Fargo Company - MarketBeat |
LeMaitre Vascular Upcoming and Recent Events
22nd of February 2024 Upcoming Quarterly Report | View | |
7th of May 2024 Next Financial Report | View | |
31st of December 2023 Next Fiscal Quarter End | View | |
22nd of February 2024 Next Fiscal Year End | View | |
30th of September 2023 Last Quarter Report | View | |
31st of December 2022 Last Financial Announcement | View |
LeMaitre Largest EPS Surprises
Earnings surprises can significantly impact LeMaitre Vascular's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Reported | Fiscal Date | Estimated EPS | Reported EPS | Surprise | |||
---|---|---|---|---|---|---|---|
2016-05-02 | 2016-03-31 | 0.1 | 0.11 | 0.01 | 10 | ||
2014-04-29 | 2014-03-31 | 0.02 | 0.01 | -0.01 | 50 | ||
2013-10-29 | 2013-09-30 | 0.04 | 0.05 | 0.01 | 25 |
LeMaitre Vascular Environmental, Social, and Governance (ESG) Scores
LeMaitre Vascular's ESG score is a quantitative measure that evaluates LeMaitre Vascular's performance and commitment regarding environmental, social, and governance (ESG) factors. These scores are becoming increasingly crucial in investment decision-making processes, providing insights into non-financial aspects of LeMaitre Vascular's operations that may have significant financial implications and affect LeMaitre Vascular's stock price as well as guide investors towards more socially responsible investments.
LeMaitre Stock Institutional Investors
Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares | Northern Trust Corp | 2024-09-30 | 312 K | Acadian Asset Management Llc | 2024-09-30 | 291 K | T. Rowe Price Associates, Inc. | 2024-09-30 | 283.1 K | Driehaus Capital Management Llc | 2024-09-30 | 266.2 K | Df Dent & Co Inc | 2024-09-30 | 258.8 K | Envestnet Asset Management Inc | 2024-09-30 | 242.5 K | Ameriprise Financial Inc | 2024-09-30 | 241.1 K | Rice Hall James & Associates, Llc | 2024-12-31 | 235.1 K | Jpmorgan Chase & Co | 2024-09-30 | 202.1 K | Blackrock Inc | 2024-09-30 | 3.7 M | Conestoga Capital Advisors, Llc | 2024-12-31 | 1.7 M |
LeMaitre Market Capitalization
The company currently falls under 'Mid-Cap' category with a current market capitalization of 2.22 B.LeMaitre Profitablity
The company has Profit Margin (PM) of 0.19 %, which maeans that even a very small decline in it revenue will erase profits resulting in a net loss. This is way below average. Similarly, it shows Operating Margin (OM) of 0.24 %, which suggests for every 100 dollars of sales, it generated a net operating income of $0.24.Last Reported | Projected for Next Year | ||
Return On Tangible Assets | 0.11 | 0.06 | |
Return On Capital Employed | 0.10 | 0.06 | |
Return On Assets | 0.08 | 0.04 | |
Return On Equity | 0.09 | 0.10 |
Management Efficiency
LeMaitre Vascular has return on total asset (ROA) of 0.0872 % which means that it generated a profit of $0.0872 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.1334 %, meaning that it created $0.1334 on every $100 dollars invested by stockholders. LeMaitre Vascular's management efficiency ratios could be used to measure how well LeMaitre Vascular manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to gain to 0.1 in 2025, whereas Return On Tangible Assets are likely to drop 0.06 in 2025. At this time, LeMaitre Vascular's Total Current Liabilities is comparatively stable compared to the past year. Liabilities And Stockholders Equity is likely to gain to about 418.7 M in 2025, whereas Non Current Liabilities Other is likely to drop slightly above 1.8 M in 2025.Last Reported | Projected for Next Year | ||
Book Value Per Share | 12.07 | 12.67 | |
Tangible Book Value Per Share | 7.71 | 8.09 | |
Enterprise Value Over EBITDA | 23.07 | 24.23 | |
Price Book Value Ratio | 4.87 | 4.64 | |
Enterprise Value Multiple | 23.07 | 24.23 | |
Price Fair Value | 4.87 | 4.64 | |
Enterprise Value | 1.2 B | 1.1 B |
Evaluating the management effectiveness of LeMaitre Vascular allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The LeMaitre Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Technical Drivers
As of the 17th of February 2025, LeMaitre Vascular secures the mean deviation of 1.3, and Risk Adjusted Performance of (0.02). Concerning fundamental indicators, the technical analysis model lets you check available technical drivers of LeMaitre Vascular, as well as the relationship between them.LeMaitre Vascular Price Movement Analysis
The output start index for this execution was twenty with a total number of output elements of fourty-one. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. LeMaitre Vascular middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for LeMaitre Vascular. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
LeMaitre Vascular Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific LeMaitre Vascular insiders, such as employees or executives, is commonly permitted as long as it does not rely on LeMaitre Vascular's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases LeMaitre Vascular insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
LeMaitre Vascular Outstanding Bonds
LeMaitre Vascular issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. LeMaitre Vascular uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most LeMaitre bonds can be classified according to their maturity, which is the date when LeMaitre Vascular has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
MPLX LP 4125 Corp BondUS55336VAK61 | View | |
MPLX LP 4875 Corp BondUS55336VAJ98 | View | |
MPLX LP 52 Corp BondUS55336VAL45 | View | |
Valero Energy Partners Corp BondUS91914JAA07 | View |
LeMaitre Vascular Predictive Daily Indicators
LeMaitre Vascular intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of LeMaitre Vascular stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
LeMaitre Vascular Corporate Filings
8K | 13th of February 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
5th of February 2025 Other Reports | ViewVerify | |
24th of January 2025 Other Reports | ViewVerify | |
10th of January 2025 Other Reports | ViewVerify | |
F4 | 26th of December 2024 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 19th of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 17th of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
8K | 16th of December 2024 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
LeMaitre Vascular Forecast Models
LeMaitre Vascular's time-series forecasting models are one of many LeMaitre Vascular's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary LeMaitre Vascular's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About LeMaitre Stock Analysis
Stock analysis is the technique used by a trader or investor to examine and evaluate how LeMaitre Vascular prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling LeMaitre shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as LeMaitre Vascular. By using and applying LeMaitre Stock analysis, traders can create a robust methodology for identifying LeMaitre entry and exit points for their positions.
Last Reported | Projected for Next Year | ||
Pretax Profit Margin | 0.18 | 0.19 | |
Operating Profit Margin | 0.17 | 0.18 | |
Net Profit Margin | 0.14 | 0.15 | |
Gross Profit Margin | 0.66 | 0.76 |
Current LeMaitre Analysis - Recommendations
We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. LeMaitre analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. LeMaitre analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target Price | Advice | # of Analysts | |
98.78 | Strong Buy | 10 | Odds |
Most LeMaitre analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand LeMaitre stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of LeMaitre Vascular, talking to its executives and customers, or listening to LeMaitre conference calls.
LeMaitre Stock Analysis Indicators
LeMaitre Vascular stock analysis indicators help investors evaluate how LeMaitre Vascular stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading LeMaitre Vascular shares will generate the highest return on investment. By understating and applying LeMaitre Vascular stock analysis, traders can identify LeMaitre Vascular position entry and exit signals to maximize returns.
Begin Period Cash Flow | 19.1 M | |
Total Stockholder Equity | 297.9 M | |
Capital Lease Obligations | 19.1 M | |
Property Plant And Equipment Net | 39.8 M | |
Cash And Short Term Investments | 105.1 M | |
Net Invested Capital | 297.9 M | |
Cash | 24.3 M | |
50 Day M A | 96.638 | |
Net Interest Income | 2.5 M | |
Total Current Liabilities | 29.9 M | |
Forward Price Earnings | 45.4545 | |
Investments | -22.9 M | |
Stock Based Compensation | 5.3 M | |
Common Stock Shares Outstanding | 22.4 M | |
Tax Provision | 8.7 M | |
Quarterly Earnings Growth Y O Y | 0.485 | |
Free Cash Flow | 29.5 M | |
Other Current Assets | 12.1 M | |
Accounts Payable | 3.7 M | |
Net Debt | -5.2 M | |
Other Operating Expenses | 156.8 M | |
Non Current Assets Total | 152.2 M | |
Liabilities And Stockholders Equity | 346.8 M | |
Non Currrent Assets Other | 3.7 M |
Additional Tools for LeMaitre Stock Analysis
When running LeMaitre Vascular's price analysis, check to measure LeMaitre Vascular's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LeMaitre Vascular is operating at the current time. Most of LeMaitre Vascular's value examination focuses on studying past and present price action to predict the probability of LeMaitre Vascular's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LeMaitre Vascular's price. Additionally, you may evaluate how the addition of LeMaitre Vascular to your portfolios can decrease your overall portfolio volatility.